We are building an innovative start-up called KNOME that operates in the field of sequenced microbiome data.
The start-up is known as KNOME and aims to act as a global marketplace where individuals, researchers, and pharmaceutical companies connect without compromising their privacy. We give our users full control over their sequenced microbiome data, including who has access to it and getting compensated for sharing it. This easily allows pharmaceutical companies to query the microbiome data they need in one platform to quickly produce better treatments. Furthermore, this will incentivize more people to get their microbiome sequenced, which enlarges the dataset. Additionally, our platform allows bulk buying of microbiome data.
This project started from a customer survey we conducted. We discovered that the main reason for individuals not undergoing sequencing was cost and fear of data exploitation. Additionally, last year 23andMe received $5 billion from pharmaceutical companies from selling their customer data and the customers were not compensated for this. At KNOME we believe this should not be the case and thereby we prioritize transparency.
I just want to ask how much pharmaceutical companies or any other companies are willing to pay for microbiome data and what are the current methods and resources of obtaining microbiome data?
ngs
metagenomics
microbiome